Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial

Mason, M and Clarke, NW and James, N and Dearnaley, D and Spears, M and Ritchie, A and Attard, G and Cross, W and Jones, R and Parker, C and Russell, J and Thalmann, G and Schiavone, F and Cassoly, E and Matheson, DJ and Millman, R and Rentsch, C and Barber, J and Gilson, C and Ibrahim, A and Logue, J and Lydon, A and Nikapota, A and O'Sullivan, J and Porfiri, E and Protheroe, A and Srihari, N and Tsang, D and Wagstaff, J and Wallace, J and Walmsley, C and Parmar, M and Sydes, M (2017) Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial. Journal of Clinical Oncology, 35 (14). ISSN 0732-183X DOI: https://doi.org/10.1200/JCO.2016.69.0677

Abstract

More Information

Divisions: Carnegie > Sport
Identification Number: https://doi.org/10.1200/JCO.2016.69.0677
Status: Published
Refereed: Yes
Publisher: American Society of Clinical Oncology
Uncontrolled Keywords: 1112 Oncology And Carcinogenesis, Oncology & Carcinogenesis,
Depositing User (symplectic) Deposited by Bayjoo, Jennifer on behalf of Matheson, David
Date Deposited: 09 Jun 2017 13:31
Last Modified: 11 Sep 2018 10:19
Item Type: Article

Download

[img]
Preview
Published Version
License: Creative Commons Attribution

| Preview

Export Citation

Share

Statistics

Additional statistics for this record